Interesting that a small Canadian company has already completed a Phase2 trial of a CETP inhbitor  (Dalcetrapib) in covid-19. No results out yet.

https://clinicaltrials.gov/ct2/show/record/NCT04676867?term=NCT04676867&draw=2&rank=1